Atrial Fibrillation: The Regular Irregularity

Introduction

  • Presenter: Brian Sheehan, Family Medicine Hospitalist

  • Career Background:

    • Started in primary care in Alaska

    • Completed a hospital medicine fellowship in the Army

    • Worked primarily as a critical care hospitalist, especially with critically ill patients

Objectives and Structure of the Presentation

  • Main Goal: Share exciting 2023 updates related to atrial fibrillation (AF) and fundamental pearls of knowledge that may be overlooked.

  • Aimed at learners across experience levels.

  • Learning objectives: In-depth discussion on everything related to atrial fibrillation.

Case Presentation

  • Patient Profile: Ms. Rose, 77-year-old female, presents with upper respiratory symptoms.

  • Heart exam reveals: Irregularly irregular rhythm, contrasted with a previous regular rhythm note from a week prior.

  • EKG findings: Narrow complex QRS with irregular time intervals.

Key Questions

  • What are the classic findings of atrial fibrillation?

    • Answers explored:

    • Irregular R-R intervals

    • Narrow complex QRS

    • Irregular atrial activity

    • Absence of distinct P waves

    • Clarification: The only component not essential in defining atrial fibrillation is narrow complex QRS.

Importance of Atrial Fibrillation

  • Atrial fibrillation's implications:

    • Associated with increased risks:

    • Stroke

    • Heart failure (particularly more prevalent in women)

    • Dementia (2x risk)

    • Increased hospitalizations (2x risk for women)

  • Epidemiological Data:

    • Most common arrhythmia globally.

    • Incidence increases with age.

    • Accounts for 500,000 annual admissions in the U.S.

    • Doubles mortality risk; tripling for women.

Understanding Atrial Fibrillation Mechanics

  • Diagram: Electrical system of the heart contrasting normal function with fibrillation-induced chaos.

    • AV node's response: Randomly conducts electrical currents due to chaotic activity.

    • Normal vs. pathological QRS complexes:

    • Narrow complex QRS: prevalent with normal conduction pathways.

    • Wide QRS: potential presence of bundle branch blocks.

Distinguishing Atrial Fibrillation from Other Conditions

  • Atrial fibrillation vs. Ventricular Tachycardia (V-Tach):

    • Key distinctions based on rhythm norms.

    • Irregular rhythms signify AF, whereas regular ones align with V-Tach.

Progression of Atrial Fibrillation

  • Paroxysmal AF: Typically tied to one node; often arises in the pulmonary sleeves—important for catheter ablation strategy targeting.

  • Progression leads to:

    • Increased nodes

    • Fibrosis making it difficult to revert to sinus rhythm over time.

Evaluation Framework for Atrial Fibrillation

  • Classic Risk Factors: Contributing to AF include:

    • Surgery (most common cause)

    • Pneumonia (second most common cause)

    • Obstructive sleep apnea

    • Note: Caffeine does not substantially relate to AF.

Management Strategies for Atrial Fibrillation

Key Management Pillars

  • Two main pillars:

    • Stroke Prophylaxis

    • Rate vs. Rhythm Control

  • Importance of covering stroke prophylaxis no matter other health concerns presented by patients.

Anticoagulation Decisions Based on CHADS-VASc Score

  • Case scenario:

    • Healthy 77-year-old female or similar: anticoagulation decision-making necessitates consideration of CHADS VASc score.

  • Introduced in 2019:

    • Women over 75 receive 2 points.

    • Importance of a threshold of 3 points for anticoagulation, particularly for women.

  • Controversy: Differences in scoring between males and females.

Updated Guidelines and Recommendations

  • 2019 Recommendations:

    • Utilize direct oral anticoagulants (DOACs) instead of warfarin for efficacy and safety

  • Warfarin remains the choice for valvular AF or in objects with end-stage renal disease.

  • Post-bariatric surgery: Recommendation shift implies warfarin usage due to DOAC absorption issues.

Final Thoughts on Anticoagulants and Atrial Fibrillation Management

  • Antiplatelets (like aspirin) do not provide stroke prophylaxis in AF settings.

  • Considering echocardiography outcomes: Moderate to severe mitral stenosis necessitates warfarin use, often related to rheumatic disease.

Has-BLED Score Considerations

  • Evaluating high-risk patients for anticoagulation:

    • Use Has-BLED scoring to modify risk (not to exclude) based on study outcomes showing better outcomes on anticoagulation—even in high-risk individuals.

Types of Atrial Fibrillation

  • Case Analysis: Determining which type of AF applies to Ms. Rose.

    • New classification stages introduced—classification stages based on structural changes and risk factor presence (staging rather than strict duration classifications).

Current Understanding of Atrial Fibrillation Management Today

  • New findings underscore timely rhythm control: the importance of managing AF less than one year and exploring ablation options.

  • Emphasis on managing tachycardia induced cardiomyopathy and guidelines established for patient management.

Use of Antidysrhythmia Medication

Medical Management of Atrial Fibrillation with RVR

  • Initial steps: Ensure patients are stable and rule out underlying causes like sepsis or dehydration before emergency pharmacological control.

  • Effective medications: IV metoprolol recommended whenever possible, avoiding central calcium channel blockers in reduced EF settings.

Amiodarone as a Control Option

  • Caution in usage even for rate control and potential adverse outcomes in patients.

Atrial Fibrillation and Surgical Management

Bridging Anticoagulation and Procedural Timing

  • Preoperative management needs to balance bleeding risk vs. stroke prevention—different timing rules for holding DOACs before procedures depending on surgery risk.

Summary of Important Considerations

Fundamental Atrial Fibrillation Management Strategies

  • Require a bi-prong approach focused on stroke prophylaxis alongside rate versus rhythm control, incorporating evidence from recent studies to reassess treatment paradigms.

  • Emphasize ongoing patient-centered shared decision-making and adjusting anticoagulation methods based on individual risk factors.

Anticipated Future Directions

  • Increased emphasis on left atrial appendage closure device usage for patients with contraindications for anticoagulation, evolving management approaches based on very recent findings and practices within cardiology.

Final Remarks and Q&A Session

  • Encourage continued discussions around atrial fibrillation management issues and forthcoming research findings that could impact treatment protocols.